Arrhythmias & electrophysiology
Prevalence, Management, and Comorbidities of Adults With Atrial Fibrillation in the United States, 2019 to 2023
Authors' conclusion
The findings of this geographically diverse and nationally representative investigation align with recent prevalence studies, highlighting the increased burden of atrial fibrillation on the United States health care system.
Study context
- Population
- US adults aged ≥18 years, Epic Cosmos platform, 2019–20234,834,977 with AF
- Participants
- 124,247,691 adults
- Outcome
- Prevalence and management of AF
Methodological detailsmulticentre, population-based
- Multicentre
- Population-based
Main finding
As reported in the abstract
Overall AF prevalence
- Overall prevalence of AF
- 3.89%
- Prevalence in adults <50 years
- 0.26%
- Prevalence in adults ≥90 years
- 24.58%
- Prevalence, rural areas
- 5.29%
- Prevalence, urban areas
- 3.66%
Observational data: associations, not effects.
Further findings
AF cohort characteristics
- Mean age (years)
- 76
- Male
- 55.43%
- Non-Hispanic White
- 83.05%
Anticoagulation
- Individuals with AF not receiving anticoagulant medication
- Roughly 30%
Original publication
Prevalence, Management, and Comorbidities of Adults With Atrial Fibrillation in the United States, 2019 to 2023. JACC Adv. Published 10 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →